Clinical Trials Directory

Trials / Completed

CompletedNCT00746343

Reducing Medical Risks in Individuals With Bipolar Disorder - Full Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
122 (actual)
Sponsor
University of Pittsburgh · Academic / Other
Sex
All
Age
18 Years – 55 Years
Healthy volunteers
Not accepted

Summary

The primary aim of this project is to understand whether it is possible to reduce medical risk factors in adults with bipolar disorder and, in doing so, to improve psychiatric and functional outcomes. We will examine the role of behavioral risk factors and presumed behavioral mediators and moderators of health risk in individuals suffering from bipolar I disorder. The investigators will employ an innovative behavioral intervention with guideline based psychiatric care ( Integrated Risk Reduction Intervention - IRRI) in order to target modifiable medical risk factors.

Detailed description

IRRI is aimed at improving sleep/wake and social rhythm disturbance and achieving modest weight reduction by increasing physical activity and improving nutrition and dietary habits, while at the same time providing optimal psychiatric care and medical monitoring. This will allow us to investigate the role that improvements in sleep/wake and social rhythm regularity, diet, and physical activity have in improving psychiatric and functional outcomes. In order to examine another set or possible pathways (i.e., that it is the amelioration or psychiatric symptoms that leads to the improvements in physical health), we will contrast outcomes of subjects receiving IRRI with those of subjects receiving psychiatric care with medical monitoring (PCMM), which incorporates the same optimal psychiatric care plus monitoring of medical conditions. These aims will be achieved in a 24-month randomized treatment trial of 144 adult subjects with bipolar I disorder.

Conditions

Interventions

TypeNameDescription
BEHAVIORALIRRISubjects will remain in their assigned treatment condition for 24 months. IRRI subjects will meet with the lifestyle coach 25-27 times throughout the duration of the study.
BEHAVIORALPCCMSubjects will remain in their assigned treatment condition for 24 months.

Timeline

Start date
2008-09-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2008-09-04
Last updated
2013-12-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00746343. Inclusion in this directory is not an endorsement.